Drug Type Herbal medicine |
Synonyms Sheng Di Huang (Rehmanniae Radix), Xuan Shen (Scrophulariae Radix), mai men dong (Ophiopogonis Radix), shan zhu yu (Corni Fructus), shan yao (Dioscoreae Rhizoma), sha yuan zi (Astragali complanati Semen), ci ji li (Tribuli Fructus), nu zhen zi (Ligustri lucidi Fructus) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anxiety Disorders | Phase 2 | US | 01 Mar 2021 | |
Bipolar Disorder | Phase 2 | US | 01 Mar 2021 | |
Depressive Disorder | Phase 2 | US | 01 Mar 2021 | |
Encephalomyelitis, Acute Disseminated | Phase 2 | US | 01 Mar 2021 | |
Gastroesophageal Reflux | Phase 2 | US | 01 Mar 2021 | |
Guillain-Barre Syndrome | Phase 2 | US | 01 Mar 2021 | |
Hypothyroidism | Phase 2 | US | 01 Mar 2021 | |
Osteoarthritis | Phase 2 | US | 01 Mar 2021 | |
Parkinson Disease, Postencephalitic | Phase 2 | US | 01 Mar 2021 | |
Sleep Initiation and Maintenance Disorders | Phase 2 | US | 01 Mar 2021 |